2016 International Congress Archives - Page 165 of 207

Safety of deep brain stimulation for movement disorders: A single-centre long-term standardized recording and analysis

C. Bagella, D. Calandrella, G. Zorzi, G. Messina, F. Carella, A. Franzini, C.E. Marras, N. Nardocci, L.M. Romito (Milan, Italy)
Safety of nelotanserin in a randomized placebo-controlled phase 2 study

W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, S. Piscitelli, M. Sanchez, W. Shanahan (New York, NY, USA)
Safety of opicapone in fluctuating Parkinson’s disease patients: Results of the 1-year extension of study BIPARK I

A. Santos, J. Ferreira, A. Lees, F. Stocchi, O. Rascol, N. Lopes, H. Gama, J.F. Rocha, P. Soares-da-Silva (Porto, Portugal)
Safety, pharmacokinetics, and efficacy of levodopa prodrug ONO-2160/CD: A study in patients with Parkinson’s disease

M. Nomoto, M. Nagai, N. Nishikawa, Y. Kagamiishi, K. Yano, M. Akisada, S. Saito, M. Yuba, A. Takeda (Tohon Ehime, Japan)
Saliva swallowing frequency measured using 24-hours ambulatory impedance-pH monitoring in patients with Parkinson’s disease and drooling

J.G. Kalf, S. Scholten, W. Hopman (Nijmegen, Netherlands)
Same cerebellar atrophy pattern in hyper- and hypokinetic movement disorders due to mitochondrial cytopathy

S.R. Schreglmann, F. Riederer, C. Ganos, G. Kägi, D. Waldvogel, U. Hidding, E. Krasemann, C.R. Baumann, K.P. Bhatia, H.H. Jung, L. Michels (London, United Kingdom)
Sarcopenia and dynapenia in patients with parkinsonism

E. Cassani, E. Cereda, G. Pinelli, L. Iorio, A. Valentino, C. Pusani, V. Ferri, C. Bolliri, M. Pasqua, G. Frazzitta, M. Barichella, G. Pezzoli (Milano, Italy)
Scores and dimensions to assess cognitive impairment in Parkinson’s disease

I. Liepelt-Scarfone, S. Gräber, A. Pilotto, D. Blum, M. Fruhmann Berger, D. Berg (Tübingen, Germany)
Screening for neuropsychiatric symptoms in Parkinson’s disease

M.J. Barrett, S.A. Sperling, B.B. Shah, J.L. Flanigan, G.F. Wooten, M.B. Harrison, C.A. Manning (Charlottesville, VA, USA)
Screening for SLC25A46 mutations in familial and sporadic ataxic patients

S. Efthymiou, C. Bettencourt, H. Houlden (London, United Kingdom)